• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,433.45 250.09
( 0.33%)
Global Indices
Nasdaq
50,311.43 281.08
(0.56%)
Dow Jones
7,466.66 12.69
(0.17%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,466.07 33.73
(0.32%)
Forex
USD-INR
96.70 0.18
(0.19%)
EUR-INR
112.25 0.09
(0.08%)
GBP-INR
129.69 0.32
(0.24%)
JPY-INR
0.61 0.00
(0.25%)

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532531
INE939A01011
356.2358719
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STAR
58.18
10681.9
EPS(TTM)
Face Value()
Div & Yield %
19.92
10
0.43
 

Man Infra acquires ultra-luxury sea-view residential development project in Bandra, Mumbai
May 18,2026

Man Infraconstruction announced the acquisition of an ultra-luxury sea-view residential development located off Bandstand, Bandra West, Mumbai. This acquisition further strengthens MICL Group's presence in one of Mumbai's most prestigious and tightly held residential micro-markets.

Strategically located off Bandstand, Bandra West, the newly acquired project is expected to have an estimated GDV of Rs 1,000+ crore and will be positioned as β€˜The One & Only' within our MS Collection Residences vertical β€” a boutique sea-view residential offering catering to the premium luxury segment.

With this addition, MICL Group's total real estate portfolio now stands at an estimated GDV of over Rs 18,575+ crores, while the launch pipeline for FY27 has expanded to nearly Rs 6,600+ crores β€” the largest launch pipeline in the Company's history.

MICL Group shall hold ~70% stake in the newly acquired off-Bandstand, Bandra West project.